Figure 8
- ID
- ZDB-FIG-221214-135
- Publication
- Poudel et al., 2022 - Resveratrol-Mediated Reversal of Doxorubicin-Induced Osteoclast Differentiation
- Other Figures
- (all 10)
- All Figure Page
- Back to All Figure Page
Reversal of Doxorubicin-induced mucositis by resveratrol. The ctsk reporter zebrafish transgenic line (Tg[ctsk:DsRed]) was exposed to different concentrations of resveratrol (RES, 75 µM and 100 µM) alone or together with doxorubicin (DOX, 17.2 µM) for 96 h. The quantification of fluorescence intensity between the treatment groups performed using fluorescent images acquired with the same parameters and analyzed with ImageJ (A). ctsk signal in the abdominal area of fish from the different treatment groups (B). One-way ANOVA, Tukey’s multiple comparisons test, *—p ≤ 0.05, ****—p ≤ 0.0001. |
Gene: | |
---|---|
Fish: | |
Conditions: | |
Anatomical Term: | |
Stage: | Days 21-29 |
Fish: | |
---|---|
Conditions: | |
Observed In: | |
Stage: | Days 21-29 |